AzTrials
AzTrials

Folic Acid DeficiencyNCT04180800

Studying the Association Between Folic Acid Deficiency and Social Isolation for Elderly Patients

An observational study of Folic Acid Deficiency and Social Isolation, run by University Hospital, Strasbourg, France at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Social isolation among elderly people is a frequent and major determinant for health. The risk of premature death is 2 to 5 time higher for socially isolated people, similarly for morbidity, duration of healing and complications rate. Read more about this study

Who is it for?
Ages 75 years and older
What is being tested?
Lubben Social Network Scale - 6
Type of treatment
Pill or oral medicine
How many people
61 participants
Where
1 siteFrance
Study dates
23 Jan 2020to 13 Aug 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Patients over 75 years old, hospitalized in geriatric rehabilitation care in Strasbourg University Hospital

Who may be able to join

  • Patients hospitalized in geriatric rehabilitation care in Strasbourg University Hospital
  • Age > 75 years
  • Patient has given his consent

Who cannot join

  • Digestive malabsorption disorder : gastrectomy, extended intestinal resection, Crohn disease, celiac disease, parenteral nutrition
  • Chronic alcoholism
  • Treatment with sulfamids, methotrexate, anti epileptic treatment (hydantoin)
  • Hemodialysis
  • Patients under protection measure (curatorship, guardianship, judicial protection)
  • Patient refuses to participate

Trial locations and contacts

1 site in 1 country.

France1 site
  • Les Hôpitaux Universitaires de Strasbourg

    Strasbourg, 67091

Other trials in France

About this study

Social isolation among elderly people is a frequent and major determinant for health.

The risk of premature death is 2 to 5 time higher for socially isolated people, similarly for morbidity, duration of healing and complications rate.

Read more

Denutrition is also frequent for elderly people with potentially serious consequences. Vitamin deficiency, especially in B9 and B12 vitamins, are often associated with denutrition among elderly people.

Folic acid (vitamin B9) is not influenced by inflammation and folic acid income are necessarily exogene. Vitamin B9 is provided by fresh fruits and vegetables, and giblets.

The investigators observed a high prevalence in folic acid deficiency for socially isolated elderly patients. The investigators made the hypothesis that a folic acid defiency is associated with social isolation for elderly people.

The primary purpose is the study of the association between folic acid deficiency (measured by dosing of plasma concentration of vitamin B9) and social isolation evaluated by Lubben Social Network Scale in 6 questions.

The secondary purposes are the study of the correlation between folic acid deficiency and social conditions, nutritional status, biological data, poly pharmacy, cognitive functions, dependency and length of stay at hospital.

Being tested
Lubben Social Network Scale - 6
Medical subject headings
Folic Acid Deficiency, Social Isolation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lubben Social Network Scale - 6Other

    One short oral interview to complete the Lubben Social Network Scale in auto-survey, translated in French. It contains 6 questions on 30 points, higher scores are associated with more social engagement, lower scores, specifically under 12/30, are associated with social isolation.

Study groups in NCT04180800
Study groupRoleWhat they receive
Folic acid deficiencyThose with a folic acid defiency
Receives: Other: Lubben Social Network Scale - 6
No deficiencyThose with no folic acid deficiency
Receives: Other: Lubben Social Network Scale - 6

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure of plasma concentration on vitamin B9 by blood test taken in regular hospital admission

    Folic acid deficiency is evaluated by dosing of plasma concentration of vitamin B9 through blood test taken in regular hospital admission. Folic acid deficiency is defined by a concentration under 3 ng/mL.

    Measured: 10 weeks

  2. Measure of social isolation by Lubben Social Network Scale in 6 questions

    Social isolation is measured by score results on LSNS-6 auto-survey. A score lower than 12/30 is associated with social isolation.

    Measured: 10 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Nov 2019
  2. Study start23 Jan 2020
  3. Primary completion23 Jan 2020
  4. Study completion13 Aug 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
61 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04180800
Sponsor's protocol ID
7483
Status last verified
Oct 2019
First submitted
1 Oct 2019
Last updated
24 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Folic Acid Deficiency and Social Isolation, run by University Hospital, Strasbourg, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure of plasma concentration on vitamin B9 by blood test taken in regular hospital admission (time frame: 10 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in